<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Preoperative CA 19-9 levels and tumor resectabilty and survival rates in pancreatic cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Preoperative CA 19-9 levels and tumor resectabilty and survival rates in pancreatic cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">Preoperative CA 19-9 levels and tumor resectabilty and survival rates in pancreatic cancer</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">CA 19-9 (U/mL)</td> <td class="subtitle1" rowspan="2">Number of patients</td> <td class="subtitle1" rowspan="2">Resectability (%)</td> <td class="subtitle1" rowspan="2">R0 resection (%)</td> <td class="subtitle1" colspan="2">Survival after resection</td> <td class="subtitle1">Survival if unresectable</td> </tr> <tr> <td class="subtitle2">5-year (%)</td> <td class="subtitle2">Median (months)</td> <td class="subtitle2">Median (months)</td> </tr> <tr> <td>&lt;5</td> <td class="centered">99</td> <td class="centered">73.7</td> <td class="centered">48.6</td> <td class="centered">21.9</td> <td class="centered">26.8</td> <td class="centered">10.1</td> </tr> <tr> <td>5 to &lt;37</td> <td class="centered">281</td> <td class="centered">79.7</td> <td class="centered">52.7</td> <td class="centered">27.2</td> <td class="centered">28.5</td> <td class="centered">9.1</td> </tr> <tr> <td>37 to &lt;100</td> <td class="centered">216</td> <td class="centered">83.3</td> <td class="centered">46.9</td> <td class="centered">19.1</td> <td class="centered">26.9</td> <td class="centered">8.6</td> </tr> <tr> <td>100 to &lt;250</td> <td class="centered">247</td> <td class="centered">82.2</td> <td class="centered">42.1</td> <td class="centered">16.8</td> <td class="centered">22.5</td> <td class="centered">5.4</td> </tr> <tr> <td>250 to &lt;500</td> <td class="centered">204</td> <td class="centered">72.1</td> <td class="centered">37.0</td> <td class="centered">8.3</td> <td class="centered">20.1</td> <td class="centered">9.2</td> </tr> <tr> <td>500 to &lt;1000</td> <td class="centered">184</td> <td class="centered">67.4</td> <td class="centered">44.7</td> <td class="centered">7.0</td> <td class="centered">15.4</td> <td class="centered">8.9</td> </tr> <tr> <td>1000 to &lt;2000</td> <td class="centered">126</td> <td class="centered">61.1</td> <td class="centered">32.5</td> <td class="centered">0.0</td> <td class="centered">12.0</td> <td class="centered">6.8</td> </tr> <tr> <td>2000 to &lt;4000</td> <td class="centered">92</td> <td class="centered">45.7</td> <td class="centered">31.0</td> <td class="centered">0.0</td> <td class="centered">12.3</td> <td class="centered">6.2</td> </tr> <tr> <td>≥4000</td> <td class="centered">94</td> <td class="centered">38.3</td> <td class="centered">27.8</td> <td class="centered">0.0</td> <td class="centered">14.4</td> <td class="centered">7.2</td> </tr> <tr> <td> </td> <td class="centered"> </td> <td class="centered"><em>p</em>&lt;0.0001</td> <td class="centered"><em>p</em> = 0.0009</td> <td class="centered"> </td> <td class="centered"><em>p</em>&lt;0.0001</td> <td class="centered"><em>p</em> = 0.065</td> </tr> </tbody></table></div><div class="graphic_lgnd">Preoperative CA 19-9 levels were available for 1106 patients with resectable and for 437 patients with unresectable pancreatic adenocarcinomas. The R0 resection rate was calculated by using resectable patients only. Including all patients with CA 19-9 ≥1000 U/mL (resectable and unresectable), a R0 resection was achieved in only 15.4% of this group. Starting in 2005, histopathologic reporting applied the refined resection margin evaluation, as detailed in a prior report (Hartwig W, Hackert T, Hinz U, et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011; 254:311-9).</div><div class="graphic_reference">Reproduced by permission from: Springer. Annals of Surgical Oncology. Hartwig W, Strobel O, Hinz U, et al. CA19-9 in potentially resectable pancreatic cancer: Perspective to adjust surgical and perioperative therapy. Ann Surg Oncol 2013; 20:2188. Copyright © 2013. <a href="https://link.springer.com/journal/10434" target="_blank">https://link.springer.com/journal/10434</a>.</div><div id="graphicVersion">Graphic 91517 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
